{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T09:46:35Z","timestamp":1772790395899,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,16]],"date-time":"2020-01-16T00:00:00Z","timestamp":1579132800000},"content-version":"vor","delay-in-days":3333,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"M.E.S.","award":["NIH-NCI-CA076639-7"],"award-info":[{"award-number":["NIH-NCI-CA076639-7"]}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.2353\/ajpath.2010.100330","type":"journal-article","created":{"date-parts":[[2010,10,22]],"date-time":"2010-10-22T20:25:46Z","timestamp":1287779146000},"page":"3169-3179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"title":["Combination Therapy with Epigallocatechin-3-Gallate and Doxorubicin in Human Prostate Tumor Modeling Studies"],"prefix":"10.1016","volume":"177","author":[{"given":"Mark E.","family":"Stearns","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael D.","family":"Amatangelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Devika","family":"Varma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Sell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaun M.","family":"Goodyear","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.2353\/ajpath.2010.100330_bib1","first-page":"236","article-title":"Clinical development plan: tea extracts, green tea polyphenols, and epigallocatechin gallate","volume":"26","author":"Kelloff","year":"1996","journal-title":"J Cell Biochem Suppl"},{"key":"10.2353\/ajpath.2010.100330_bib2","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/01635589809514697","article-title":"Green tea and cancer in humans: a review of the literature","volume":"31","author":"Bushman","year":"1998","journal-title":"Nutr Cancer"},{"key":"10.2353\/ajpath.2010.100330_bib3","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/10408690390826464","article-title":"Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions","volume":"43","author":"Higdon","year":"2003","journal-title":"Crit Rev Food Sci Nutr"},{"key":"10.2353\/ajpath.2010.100330_bib4","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/00008469-200310000-00007","article-title":"Protective effects of green tea extracts (Polyphenon E and EGCG) on human cervical lesions","volume":"12","author":"Ahn","year":"2003","journal-title":"Eur J Cancer Prev"},{"key":"10.2353\/ajpath.2010.100330_bib5","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1517\/13543784.13.12.1541","article-title":"Agents in development for prostate cancer prevention","volume":"13","author":"Nelson","year":"2004","journal-title":"Expert Opin Invest Drugs"},{"key":"10.2353\/ajpath.2010.100330_bib6","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/ijc.11550","article-title":"Protective effect of green tea against prostate cancer: a case-control study in southeast China","volume":"108","author":"Jian","year":"2004","journal-title":"Int J Cancer"},{"key":"10.2353\/ajpath.2010.100330_bib7","doi-asserted-by":"crossref","first-page":"10350","DOI":"10.1073\/pnas.171326098","article-title":"Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols","volume":"98","author":"Gupta","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.2353\/ajpath.2010.100330_bib8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/01926230390173842","article-title":"A grading scheme for the assessment of proliferative lesions of the mouse prostate in the TRAMP model","volume":"31","author":"Suttie","year":"2003","journal-title":"Toxicol Pathol"},{"key":"10.2353\/ajpath.2010.100330_bib9","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1158\/1940-6207.CAPR-09-0010","article-title":"Lack of evidence for green tea polyphenols as DNA methylation inhibitors in murine prostate","volume":"2","author":"Shannon","year":"2009","journal-title":"Cancer Prevention Research"},{"key":"10.2353\/ajpath.2010.100330_bib10","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1006\/abio.1997.2098","article-title":"Chemiluminescence\u2013high-performance liquid chromatographic determination of tea catechin, (-)-epigallocatechin 3-gallate, at picomole levels in rat and human plasma","volume":"248","author":"Nakagawa","year":"1997","journal-title":"Anal Biochem"},{"key":"10.2353\/ajpath.2010.100330_bib11","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1158\/0008-5472.CAN-06-4429","article-title":"Identification of putative stem cell markers, CD133 and CXCR4, in hTERT-immortalized primary nonmalignant and malignant tumor-derived human prostate epithelial cell lines and in prostate cancer specimens","volume":"67","author":"Miki","year":"2007","journal-title":"Cancer Res"},{"key":"10.2353\/ajpath.2010.100330_bib12","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/pros.20918","article-title":"Dysplasia of human prostate CD133hi SPs in NOD-SCIDs is blocked by c-myc anti-sense","volume":"69","author":"Goodyear","year":"2009","journal-title":"The Prostate"},{"key":"10.2353\/ajpath.2010.100330_bib13","first-page":"71","article-title":"Role of tumor initiating cells in prostate cancer","volume":"5","author":"Goodyear","year":"2009","journal-title":"Trends in Cancer Res"},{"key":"10.2353\/ajpath.2010.100330_bib14","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J Immunol Methods"},{"key":"10.2353\/ajpath.2010.100330_bib15","first-page":"2.82","volume":"1","author":"Sambrook","year":"2003"},{"key":"10.2353\/ajpath.2010.100330_bib16","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1158\/0008-5472.CAN-04-4100","article-title":"Sell, C Insulin-like growth factor 1 (IGF-1) induction of vascular endothelial growth factor (VEGF) is dependent upon activated","volume":"65","author":"Stearns","year":"2005","journal-title":"Ras Cancer Res"},{"key":"10.2353\/ajpath.2010.100330_bib17","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1158\/1535-7163.MCT-06-0788","article-title":"Kaempferol induces apoptosis in glioblastoma cells through oxidative stress","volume":"6","author":"Sharma","year":"2007","journal-title":"Mol Cancer Ther"},{"key":"10.2353\/ajpath.2010.100330_bib18","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s10585-009-9242-2","article-title":"Invasive prostate cancer cells are tumor initiating cells that have a stem cell-like genomic signature","volume":"26","author":"Klarmann","year":"2009","journal-title":"Clin Expl Metastsis"},{"key":"10.2353\/ajpath.2010.100330_bib19","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1002\/pros.20945","article-title":"Role of the VEGFR3\/VEGFD receptor axis in TGF\u03b21 activation of primary prostate cell lines","volume":"69","author":"Goodyear","year":"2009","journal-title":"The Prostate"},{"key":"10.2353\/ajpath.2010.100330_bib20","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0091-7435(92)90042-G","article-title":"Tea components: antimutagenic and anticarcinogenic effects","volume":"21","author":"Mukhtar","year":"1992","journal-title":"Prev Med"},{"key":"10.2353\/ajpath.2010.100330_bib21","first-page":"157","article-title":"IL-10 blocks collagen IV invasion by \u201cinvasion stimulating factor\u201d activated PC-3 ML cells: upregulation of TIMP-1 expression","volume":"7","author":"Stearns","year":"1995","journal-title":"Oncol Res"},{"key":"10.2353\/ajpath.2010.100330_bib22","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0304-3835(94)90063-9","article-title":"Inhibition of spontaneous and photo-enhanced lipid peroxidation in mouse epidermal microsomes by epicatechin derivatives from green tea","volume":"79","author":"Katiyar","year":"1994","journal-title":"Cancer Lett"},{"key":"10.2353\/ajpath.2010.100330_bib23","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1349-7006.1994.tb02085.x","article-title":"Inhibitory effects of (-)-epigallocatechin gallate on spontaneous hepatoma in C3H\/HeNCrj mice and human hepatoma-derived PLC\/PRF\/5 cells","volume":"85","author":"Nishida","year":"1994","journal-title":"Jpn J Cancer Res"},{"key":"10.2353\/ajpath.2010.100330_bib24","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1248\/yakushi1947.116.5_388","article-title":"Effect of tea-leaf saponin on blood pressure of spontaneously hypertensive rats","volume":"116","author":"Sagesaka-Mitane","year":"1996","journal-title":"Yakugaku Zasshi"},{"key":"10.2353\/ajpath.2010.100330_bib25","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1248\/bpb.18.1006","article-title":"Effect of tea (Camellia sinensis L.) on lipid peroxidation in rat liver and kidney: a comparison of green and black tea feeding","volume":"18","author":"Sano","year":"1995","journal-title":"Biol Pharm Bull"},{"key":"10.2353\/ajpath.2010.100330_bib26","first-page":"60","article-title":"Studies on useful components of tea in leaves of the Genus Camellia","volume":"21","author":"Nagata","year":"1986","journal-title":"Bull Nat Res Inst Tea"},{"key":"10.2353\/ajpath.2010.100330_bib27","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0378-4274(99)00290-8","article-title":"Efficacies of tea components on Dox induced antitumor activity and reversal of multidrug resistance","volume":"114","author":"Sadzuka","year":"2000","journal-title":"Toxicology Letters"},{"key":"10.2353\/ajpath.2010.100330_bib28","first-page":"153","article-title":"Modulation of cancer chemotherapy by green tea","volume":"4","author":"Sadzuka","year":"1998","journal-title":"Clin Cancer Res"},{"key":"10.2353\/ajpath.2010.100330_bib29","first-page":"44","article-title":"Synergistic effects of (-)-epigallocatechin gallate with (-)-epicatechin, sulindac, or tamoxifen on cancer-preventive activity in the human lung cancer cell line PC-9","volume":"59","author":"Suganuma","year":"1999","journal-title":"Cancer Res"},{"key":"10.2353\/ajpath.2010.100330_bib30","doi-asserted-by":"crossref","first-page":"4303","DOI":"10.1158\/0008-5472.CAN-06-4699","article-title":"A novel PEGCG of the green tea polyphenol (-)-epigallocatechin-3-gallate as a potential anticancer agent","volume":"67","author":"Landis-Piwowar","year":"2007","journal-title":"Cancer Res"},{"key":"10.2353\/ajpath.2010.100330_bib31","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1242\/jcs.114.21.3865","article-title":"Identification and isolation of human prostate epithelial stem cells based on \u03b12\u03b21-integrin expression","volume":"114","author":"Collins","year":"2001","journal-title":"J Cell Sci"},{"key":"10.2353\/ajpath.2010.100330_bib32","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ejcb.2004.12.019","article-title":"Identification of a stem cell candidate in the normal human prostate gland","volume":"84","author":"Schmelz","year":"2005","journal-title":"Eur J Cell Biol"},{"key":"10.2353\/ajpath.2010.100330_bib33","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1101\/gad.1190504","article-title":"p63 and the epithelial stem cell: more than status quo?","volume":"18","author":"McKeon","year":"2004","journal-title":"Genes Development"},{"key":"10.2353\/ajpath.2010.100330_bib34","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1242\/jcs.01222","article-title":"CD133, a novel marker for human prostatic epithelial stem cells","volume":"117","author":"Richardson","year":"2004","journal-title":"J Cell Sci"},{"key":"10.2353\/ajpath.2010.100330_bib35","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/nature07427","article-title":"Generation of a prostate from a single adult stem cell","volume":"456","author":"Leong","year":"2008","journal-title":"Nature"},{"key":"10.2353\/ajpath.2010.100330_bib36","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/pros.20895","article-title":"Oct4A is expressed by a subpopulation of prostate neuroendocrine cells","volume":"69","author":"Sotomayor","year":"2009","journal-title":"Prostate"},{"key":"10.2353\/ajpath.2010.100330_bib37","doi-asserted-by":"crossref","first-page":"9703","DOI":"10.1158\/0008-5472.CAN-08-3084","article-title":"The role of CD133 in normal human prostate stem cells and malignant cancer-initiating cells","volume":"68","author":"Vander Griend","year":"2008","journal-title":"Cancer Res"},{"key":"10.2353\/ajpath.2010.100330_bib38","doi-asserted-by":"crossref","first-page":"6942","DOI":"10.1073\/pnas.0502320102","article-title":"The Sca-1 cell surface marker enriches for a prostate-regenerating cell subpopulation that can initiate prostate tumorigenesis","volume":"102","author":"Xin","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.2353\/ajpath.2010.100330_bib39","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0304-3835(98)00185-2","article-title":"Enhancing effects of green tea components on the antitumor activity of adriamycin against M5076 ovarian sarcoma","volume":"133","author":"Sugiyama","year":"1998","journal-title":"Cancer Lett"},{"key":"10.2353\/ajpath.2010.100330_bib40","doi-asserted-by":"crossref","first-page":"763","DOI":"10.4161\/cbt.6.5.3996","article-title":"Cancer stem-like cells in human prostate carcinoma cells DU145: the seeds of the cell line?","volume":"6","author":"Wei","year":"2007","journal-title":"Cancer Biol Ther"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944010629409?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944010629409?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:54:47Z","timestamp":1762080887000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944010629409"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S0002944010629409"],"URL":"https:\/\/doi.org\/10.2353\/ajpath.2010.100330","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combination Therapy with Epigallocatechin-3-Gallate and Doxorubicin in Human Prostate Tumor Modeling Studies","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.2353\/ajpath.2010.100330","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}